Davita Inc -Dialysis Provider - Hemodialysis Services- News
International Congress on Renal Nutrition and Metbolism 2012
Nephrology Research Interviews Updated 11/10/2012 |
Hemodialysis.com Author Interview: Michael Phillips DaVita Inc., Denver, CO
|
Hemodialysis.com Authors' Interview: Dr. T Christopher Bond
Affiliations: DaVita Clinical Research, Inc, Minneapolis, MN |
Hemodialysis.com Authors' Interview: Dr. T Christopher Bond
Authors: T Christopher Bond, PhD1, Tracy J Mayne, PhD1, Jamie P Dwyer, MD2, Mohammed Sika, PhD2, Robert Niecestro, PhD3
Affiliations: 1. Davita Clinical Research, Inc, Minneapolis, MN; 2. Vanderbilt University, Nashville, TN; 3.
Keryx Biopharmaceuticals, Inc, New York, NY |
Hemodialysis.com Authors' Interview: Scott Sibbel, PhD, MPH,
DaVita Clinical Research
Authors: Scott Sibbel1, Tracy Mayne1, Mahesh Krishnan1, Allen Nissenson2, David Van Wyck2
Affiliations: 1. DaVita Clinical Research, Inc, Minneapolis, MN; 2.
DaVita Inc, Denver, CO |
Hemodialysis.com Authors' Interview:
Mahesh Krishnan, MD, MPH, MBA, FASN, Allen Nissenson, MD, FASN
A Comparative Analysis of Vascular Access and Immunization Between For Profit and Nonprofit
Mahesh Krishnan, MD, FASN, Allen R. Nissenson, MD, FASN, Rachel Feldman, Mark Desmarais, Lianna Weissblum
Affiliations: DaVita Clinical Research, Minneapolis, MN; DaVita Inc., Denver, CO
ASN 2102 Abstract [TH-PO769] |
Hemodialysis.com Authors' Interview:
Mahesh Krishnan, MD, MPH, MBA, FASN, Allen Nissenson, MD, FASN
Affiliations:
1DaVita Clinical Research, Minneapolis, MN; 2DaVita Inc., Denver, CO; |
Hemodialysis.com Author Interview : Dr. T. Christopher Bond, PhD
|
Hemodialysis.com Author Interview: Thomas Alfieri, PhD
Title: Reasons for Phosphate Binder Discontinuation Vary by Binder Type
Authors: Thomas Alfieri, PhD,1 Steven Wang, PhD,1 Peter Braunhofer, MS,2 Britt Newsome, MD, MPH, MSPH3
Affiliations: 1DaVita Inc, Denver, CO; 2Vifor Pharma, Glattbrugg, Switzerland; 3Denver Nephrology, Denver, CO |
Hemodialysis.com Author Interview:
Hemoglobin Trends in Incident End-Stage Renal Disease Patients from 2008-2011
Authors:
Scott Sibbel, PhD1 and 1 Joe Weldon, MBA;1 Rhoda Silva Brown;1 Allen Nissenson, MD, FASN;1 Mahesh Krishnan, MD, MBA, MPH, FASN1
Affiliations: 1DaVita Inc., Denver, CO |
Hemodialysis.com Author Interview: Thomas F. Parker, III, MD
Title: Extracellular Volume Control to Decrease Hospitalizations
Authors: Thomas F. Parker, III, MD;1 Raymond M. Hakim, MD;2 Allen R. Nissenson, MD;3 Mahesh Krishnan, MD, MPH, MBA;3 T. Christopher Bond, PhD;3 Franklin W. Maddux, MD;4 Kevin Chan, MD4
Affiliations: 1Renal Ventures Management; 2Vanderbilt University School of Medicine; 3DaVita, Inc; 4Fresenius Medical Care |
Presenting author: T. Christopher Bond, PhD
ERYTHROPOIESIS STIMULATING AGENT (ESA) USE IS INCREASED FOLLOWING MISSED DIALYSIS SESSIONS
T. Christopher Bond1, Jaime Rubin1, Steven Wang1, Alex Yang2
1DaVita Clinical Research, Minneapolis, MN, USA; 2Affymax, Palo Alto, CA, USA |
ICRNM poster title: Practices and Opinions on In-Center Food Consumption across 1,223 Facilities in the United States
Debbie Benner |
THE IMPACT OF DIETITIAN INTERVENTION UPON ACHIEVING QUALITY PATIENT DIALYSIS OUTCOMES IN SAUDI ARABIA
Archie D. Bunani, Ali Mohammed Allehbi
Presented at the 16th International Congress on Renal Nutrition and Metabolism (ICRNM)-
1st World Renal Nutrition Week on June 26-29, 2012 |
International Congress on Renal Nutrition and Metabolism 2012
Presenting author: T. Christopher Bond, PhD
INCREASES IN ERYTHROPOIESIS STIMULATING AGENT (ESA) USE AFTER HOSPITALIZATION OF END STAGE RENAL DISEASE (ESRD) PATIENTS
T. Christopher Bond1, Jaime Rubin1, Steven Wang1, Alex Yang2
1DaVita Clinical Research, Minneapolis, MN, USA; 2Affymax, Palo Alto, CA, USA |
|
Mary Burgess |
| |
|
MINNEAPOLIS, Jun 13, 2012 (BUSINESS WIRE) -- DaVita Clinical Research(R) (DCR(R)), a provider of clinical research services focused on kidney research as well as a multitude of specialty therapeutic populations, presented several posters at the 17th Annual International Society for Pharmacoeconomics and Outcomes Research (ISPOR) International Meeting in Washington, D.C., June 2-6, 2012. |
DaVita Sets Corporate Environmental Goals for US Dialysis Operations:
Measures Focus on Reduction in Energy, Paper and Water Consumption |
|
| Interviews with DaVita Researchers:13 Abstracts Presented at Spring 2012 NKF |
T. Christopher Bond1, Jaime Rubin1, Steven Wang1, Alex Yang2; Mahesh Krishnan1. 1DaVita
Clinical Research, Minneapolis, MN, USA; 2Affymax, Palo Alto, CA, USA
|
T. Christopher Bond1, Jaime Rubin1, Steven Wang1 and Alex Yang2. 1DaVita Clinical Research,
Minneapolis, MN, USA; 2Affymax, Inc., Palo Alto, CA, USA
|
Steven Wang1, T. Christopher Bond1, Jaime Rubin1, Alex Yang2 1DaVita Clinical Research,
Minneapolis, MN, USA; 2Affymax, Palo Alto, CA, USA
|
Shaun Boyd1, T. Christopher Bond1, Tonya Zimmerman1, Kathy Parker1, Darlene Griffin1, Duane
Dunn1, 1DaVita Inc., Denver, CO, USA
|
Eric Franco1; Edward Jhu2; Jess Parks1; Allen R. Nissenson1; Stephen McMurray1 1DaVita Inc,
Denver, CO, USA; 2Milliman, Seattle, WA, USA
|
Jaime Rubin1, T. Christopher Bond1, Steven Wang1, Alex Yang2. 1DaVita Clinical Research,
Minneapolis, MN, USA; 2Affymax, Palo Alto, CA, USA
|
|
|
Scott Sibbel1, Linda H. Ficociello2, Michael Black2, Mayuri Thakuria2, Claudy Mullon2, Jose
Diaz-Buxo2, Thomas Alfieri1, 1DaVita Clinical Research, Minneapolis, MN; 2Fresenius MedicalCare, Waltham, MA, USA
|
Richard Mutell, Jaime Rubin, T. Christopher Bond, Tracy Mayne DaVita Clinical Research,Minneapolis, MN,
|
Richard Mutell, Jaime Rubin, T. Christopher Bond, Tracy Mayne. Davita Clinical Research,Minneapolis, MN,
|
Matt Stricherz2, 3, Jane Kwatcher1, Andrea Mora1, Jena Rendon Muhr1, 1DaVita, Inc, Denver ,CO,
2Cheyenne River Sioux Tribe, Eagle Butte, SD, 3Sanford Health, Sioux Falls, SD, USA
|
Operated By a Large Dialysis Provider (LDO)
Joanne Brady, Benjamin Chen, Tom Seguine, David Stone, Robert Provenzano. DaVita Inc.,Denver, CO, USA
|
|
Shapiro calls for physician education, therapeutic improvement, new techniques
DENVER, Mar 30, 2012 (BUSINESS WIRE) -- DaVita Inc. , a leading provider of kidney care services that is committed to improving the quality of life for those diagnosed with chronic kidney disease (CKD), today announced that Dr. Mark Shapiro spoke at the first-ever National Home Dialysis Summit in Washington, D.C., on Thursday.
|
DENVER--(BUSINESS WIRE)--DaVita Inc. (NYSE: DVA), a leading provider of kidney care services that is committed to improving the quality of life for those diagnosed with chronic kidney disease (CKD), today announced important emergency preparedness information and resources for dialysis patients during upcoming tornado, hurricane and flood seasons this spring.
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
DENVER, Oct 25, 2011 (BUSINESS WIRE) -- DaVita Inc. DVA (the "Company"), a leading provider of kidney care services for those diagnosed with chronic kidney disease (CKD), announced today that it has been advised that it will be receiving a request for documents, which could include an administrative subpoena from the Office of Inspector General for the U.S. Department of Health and Human Services. The request is in connection with an inquiry by the United States Attorney's office for the Eastern District of New York regarding payment for infusion drugs covered by the New York Medicaid composite payment system for dialysis. We believe this inquiry is civil in nature. We do not know the time period covered by the inquiry.
|
|
DaVita’s First Solar Thermal Dialysis Clinic Trial Shows Substantial Energy Reduction
DENVER (Sept. 29, 2011) – DaVita Inc. (NYSE: DVA), a leading provider of kidney care services committed to improving the quality of life for those diagnosed with chronic kidney disease (CKD), today announced the company’s first-ever dialysis clinic using solar thermal technology has shown a 75 percent reduction in natural gas consumption versus comparable DaVita facilities in the region. |
|
|
|
|
|
Davita Bridge of Life - DaVita Medical Missions today announced an August 2011 mission to Guatemala to establish an acute care dialysis facility in San Felipe. The charity will open a clinic for those with acute kidney failure in the National Hospital, Pedro de Bethancourt. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Hemodialysis.com presents information about the major companies that provide hemodialysis and other dialysis services.
Davita Inc.
Summary facts regarding Davita Inc.:
DaVita Inc., a Fortune 500® company, is a leading provider of kidney care in the United States , delivering dialysis services and education to patients with chronic kidney failure and end stage renal disease.
· DaVita operates or provides administrative services at over 1,500 outpatient dialysis facilities and acute units in approximately 720 hospitals located in 43 states and the District of Columbia , serving approximately 118,000 patients.
· DaVita develops, participates in and donates to numerous programs dedicated to transforming communities and creating positive, sustainable change for children, families and our environment.
· The company’s leadership development initiatives and corporate social responsibility efforts have been recognized by Fortune, Modern Healthcare, Newsweek and WorldBlu, among others.
· Headquarters: Lakewood , Colorado .
· www.davita.com
Below is an excerpt from an interview with DaVita CEO and Chairman , Kent Thiry, conducted by Latif Lewis and published in DailyFinance on December 26, 2009.
DailyFinance: For our readers who may not be familiar with DaVita, can you describe your business model?
Kent Thiry: Most of us have a couple of kidneys. These kidneys are amazing organs - some of the most complex, sophisticated organs in the human body. This is why they've been so difficult to replicate compared to other organs like the heart, lungs and others. Normally, our blood is cleansed through urination. If you’ve lost kidney function, your blood cannot be cleansed in this manner.
Therefore, when the kidneys fail, you have two options: dialyze or be one of the fortunate few to get a transplant. We operate the facilities that people visit if their kidneys fail and they can't get a transplant.
Our facilities care for these people - typically three times a week - four hours each time. Their blood is removed from their body, cleansed of all the toxins and then put back in with additional nutrients.
We do that at more than 1,500 centers across America for 118,000 patients - every single week.
As a health care service provider, what's your view on the health care legislation currently being debated in Congress?
Kent Thiry: For us, 85% of our patients are in Medicare - and the government doesn't cover the full cost of their care. So the other 15% of our patients have to pay extra in order to make up for the government deficit.
So, if a Medicare extension means that human beings who are not getting good care today can get good care, that's great. But in our particular community - the dialysis community - we already take care of everybody and for us it could be quite economically dangerous. For example…to the extent that we end up with more patients at Medicare rates, then we have a lot of facilities that are at risk of being closed.
Positively, we have done a number of tests with the government over the last three years and have proven that by providing more integrated patient care, we can simultaneously dramatically reduce the total cost of care and improve quality.
This is the part of health-care legislation that is very exciting for us.
hemodialysis Keywords | hemodialysis Tags | hemodialysis Keyword Cloud
| |
|
|
|
